Literature DB >> 28129481

Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab.

K C Wei1, Y H Wang1,2, W H Wang2, W Chen3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28129481     DOI： 10.1111/jdv.14144

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report.

Authors:  Yajuan Shao; Chunmei Bai; Jian Sun; Xin Gao
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

Review 2.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 3.  Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.

Authors:  Fahimeh Abdollahimajd; Mohammad Shahidi-Dadras; Reza M Robati; Sahar Dadkhahfar
Journal:  Arch Acad Emerg Med       Date:  2020-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.